Home > Jones Day > Offices > Office Profile

Jones Day

  - Office Profile

                  Firm Logo for Jones Day
Jones Day 
Munich, Germany Office
View all offices

Prinzregentenstr. 11
80538  Munich, Germany

Telephone: +49 89 20 60 42-200
Telecopier: +49 89 20 60 42-293

Profile Visibility
#19 in weekly profile views out of 168 law firms in Munich, Germany
#9 in weekly profile views out of 281,287 total law firms Overall


Specific Practice & Industry Groups Details:
Banking & FinanceBusiness Restructuring & Reorganization
Employee Benefits & Executive CompensationIntellectual Property
Labor & EmploymentLife Sciences
M&APrivate Equity
Real Estate

Statement of Practice Summary:
Antitrust; Competition Law; Banking Law; Finance; Business and Tort Litigation - USA; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Global Disputes; Government Regulation; Health Care; Insurance Recovery; Intellectual Property; Issues; Appellate Practice; Labor and Employment; Life Sciences; Mergers and Acquisitions; Private Equity; Projects and Infrastructure; Real Estate; Securities Litigation; SEC Enforcement; Tax Law.

Documents by Lawyers at this office
Subscribe to this feed

The EPO's Undisclosed Disclaimers Trap-A Possible Way Out
Roland J. Graf,Sven Rihm,Bojan Savic, June 24, 2015
In its decision G 1/03, the jurisdiction of the European Patent Office ("EPO"), in particular the Enlarged Board of Appeal, has developed a possibility to disclaim novelty-destroying subject matter disclosed in prior art under Article 54(3) EPC, i.e., prior art filed before, but published...

Clarifying or Confirming the Extent of Process Exclusion under Art. 53(b) EPC? Decisions G 2/12 and G 2/13 of the Enlarged Board of Appeal of the European Patent Office
Olga Bezzubova,Diana C. Leguizamon-Morales,John Podtetenieff, June 17, 2015
The Enlarged Board of Appeal ("EBA") recently issued its joint decision on referrals G 2/12 and G 2/13—known as "Tomatoes II" and "Broccoli II"—clarifying the European Patent Office's ("EPO") position on the patentability of plants and plant parts...

FDA Finalizes Three Guidance Documents on Biosimilars
Edgar J. Asebey,Maureen Bennett,Christian B. Fulda,Colleen Heisey,Christopher M. Mikson, May 15, 2015
FDA recently finalized three draft guidance documents addressing scientific and regulatory issues associated with the development and licensure of biosimilars.

Languages: English, Farsi, French, German, Hungarian, Italian, Polish, Romanian and Spanish.

Return to the Jones Day Firm Overview


Complete a Client Review

Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.

Purchase Report

Buy an atVantage Firm Profile for insight into a law firm's litigation, bankruptcy, corporate transaction and patent prosecution experience.

Compare this Firm

Compare this firm to other firms in your Favorites.

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.